CVI Holdings’s Biodesix BDSX Stock Holding History

CVI Holdings’s Portfolio BDSX Stock Details BDSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	$59K	Buy	+1,927	New	+$55K	0.05%	46

Other funds holding BDSX

Telemark Asset Management Boston, Massachusetts $1.38B AUM 71.45% 1-Year Est. Return

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return

Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

Monashee Investment Management Boston, Massachusetts $59.6M AUM 181.61% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

CVI Holdings's BDSX Position: Q2 2024 in Review

CVI Holdings opened a new position in Biodesix (BDSX) in Q2 2024: 1,927 shares worth $59K. The stake represents 0.05% of the portfolio and ranks #46 among its holdings.

46 funds tracked by Wall St. Rank hold BDSX as of Q2 2024.

CVI Holdings held 1,927 shares of Biodesix worth $59K as of Q2 2024.
Biodesix was a new CVI Holdings position in Q2 2024.
Biodesix made up 0.05% of CVI Holdings's portfolio in Q2 2024, its #46 holding.
46 funds tracked by Wall St. Rank held Biodesix as of Q2 2024.

Based on CVI Holdings's 13F filing for Q2 2024, filed 15 Aug 2024.